Life Science AllianceSystems BiologyPeer-reviewed journal article
Analysis of context-specific KRAS-effectors (sub)complexes in Caco-2 cells
Camille TernetiD, Philipp JunkiD, Thomas SevriniD, Simona CatozziiD, Erik WåhléniD, Johan HeldiniD, Giorgio OlivieroiD, Kieran J. WynneiD, Christina KieliD
Abstract
Ras is a key switch controlling cell behavior. In the GTP-bound form, Ras interacts with numerous effectors in a mutually exclusive manner, where individual Ras-effectors are likely part of larger cellular (sub)complexes. The molecular details of these (sub)complexes and their alteration in specific contexts is not understood. Focusing on KRAS, we performed affinity purification (AP)-mass spectrometry (MS) experiments of exogenous expressed FLAG-KRAS WT and three oncogenic mutants ( genetic contexts) in the human Caco-2 cell line, each exposed to 11 different culture media ( culture contexts) that mimic conditions relevant in the colon and colorectal cancer. We identified four effectors present in complex with KRAS in all genetic and growth contexts ( context-general effectors). Seven effectors are found in KRAS complexes in only some contexts ( context-specific effectors). Analyzing all interactors in complex with KRAS per condition, we find that the culture contexts had a larger impact on interaction rewiring than genetic contexts. We investigated how changes in the interactome impact functional outcomes and created a shiny app for interactive visualization. We validated some of the functional differences in metabolism and proliferation. Finally, we used networks to evaluate how KRAS effectors are involved in the modulation of functions by random walk analyses of effector-mediated (sub)complexes. Altogether, our work shows the impact of environmental contexts on network rewiring, which provides insights into tissue-specific signaling mechanisms. This may also explain why KRAS oncogenic mutants may be causing cancer only in specific tissues despite KRAS being expressed in most cells and tissues.
- Citations
- 6
- FWCI
- 0.53
- Field percentile
- top 45%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modulation of fibroblasts phenotype by colorectal cancer cells-secreted factors is mostly independent of oncogenic KRAS
P. Dias Carvalho, S. Mendonca, … S. Velho·CellsPeer-reviewed·Aug 11, 2022
- Baseline expression of c-Myc defines the tissue specificity of oncogenic K-Ras
Olesja Popow, Qing Yu, … Kevin M. Haigis·bioRxiv·Jul 21, 2025
- Mutant KRAS-associated proteome is mainly controlled by exogenous factors
P. Dias Carvalho, F. Martins, … S. Velho·bioRxiv·Jan 5, 2022
- Remodeling of KRAS interactome induced by clinically relevant RAS inhibitors reveals convergent responses and a KRAS-mediated regulation of directional cell migration
Yang Yang, Charles Y. Cho, … Jacob R. Haling·bioRxiv·Nov 14, 2025
- Interplay Between KRAS and LZTR1 Protein Turnover, Controlled by CUL3/LZTR1 E3 Ubiquitin Ligase, is Disrupted by KRAS Mutations
Andreas Damianou, Zhu Liang, … Benedikt Mathias Kessler·bioRxiv·Nov 23, 2021
- KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation
T. H. Tran, A. H. Chan, … D. K. Simanshu·bioRxiv·Jul 31, 2020